PhinC Development has highly qualified scientists in clinical pharmacology, pharmacokinetics, and biostatistics in a wide range of therapeutic areas. All of them have a deep knowledge in drug development and bring their expertise to develop useful and creative PopPK, PBPK and PK/PD models. Furthermore, our quality system, information systems, document management, regulatory and best practices compliance are internally managed and sustained by our support staff. PhinC Development can also mobilize a pool of 7 highly qualified experts in bioanalysis, scientific writing and medical officers.
Bernard is President and co-founder of PhinC Development. He is an expert in early drug development. With more than 25 years of experience, he held many positions in pharmaceutical industry as Biostatistician, project leader of early drug development and pharmacometrics director.
He holds two Master's degrees in physiology & molecular biology and in Biostatistics, and a Post Graduate Diploma in clinical research and epidemiology.
Virginie is Vice-president and co-founder of PhinC Development. She is a Pharmacokinetic, PBPK expert, and Consultant in Pharmacometrics. She has developed the PBPK practices within the company since 2012 and she manages the PBPK unit. With more than 25 years of experience, she held many positions in pharmaceutical industry as a PK project leader, Head of the Pharmacokinetic unit and Pharmacometrician. She is a Doctor in Pharmacy and she holds two university degrees in Pharmacokinetic and in Biostatistics.
Mathieu is co-founder of PhinC Development. He is a Pharmacometrician and Biostatistician expert with more than 20 years of experience in pharmaceutical industry. Team leader of population PK-PD modeling within the company, he previously worked as a Biostatistician, head of Biostatistics and Pharmacometrician. Mathieu holds a Master's degree in Applied Mathematics and a Post Graduate Diploma in mathematics modeling and informatics methods.
Eric is associate director and co-founder of PhinC Development. With more than 25 years of experience, he is a clinical development expert and pharmacometrician. He worked for many years as a Pharmacokinetic Project Manager and Pharmacometrician. He also held the position of Manager of Early phase Clinical Projects within an integrated phase I CRO. Eric holds a Master's degree in Biochemistry and a PhD in Pharmacy.
Sabrina is a Senior Clinical Project Manager and Pharmacokineticist. With more than 15 years of experience in the field, she has held several positions. From Clinical Project Manager to Pharmacist in Regulatory Affairs and Pharmacokineticist, Sabrina has worked on various regulatory issues in a large organization. She is a Doctor in Pharmacy and she holds a Master's degree in Clinical and Pharmaceutical Development.
Sarah is an Engineer in Biostatistics and Pharmacometrics, responsible for QT/QTc analysis, PK and PD modeling and statistical analysis related to the clinical development. She worked in several clinical organizations, where she acquired skills on data management and developed mechanistic models on pharmacokinetics. Sarah holds a Master's degree in Clinical Pharmacology Modeling and Epidemiology as well as an Engineering Degree in Statistics.
Jérémy is a Pharmacometrician specialized in PBPK. Within the company, he is a major contributor to PBPK practices and new application such as modeling of intra-articular injection.
He completed his PhD in biopharmaceutics and pharmacokinetics in the UK. During this period, he worked on various projects involving oral drug solubility and PBPK modeling.
Jeremy is a Doctor in Pharmacy and he holds a Master's degree in Pharmacokinetics.
Michaël is Pharmacometrician and Pharmacokinetics Project Leader. Before joining the company, he worked for several years as a Clinical Research Scientist and PK / PD Scientist in pre-clinical and clinical Full-Service CRO. Michaël holds a Master's Degree (M.Sc.) in Pharmacology with specialization in neuropharmacology, as well as a university degree in Biomedical Sciences from the University of Montreal.
Guillaume is a Clinical programmer and Data Analyst at PHINC. Prior to joining the company, he worked more than four years as a Pharmacist specializing in clinical data management on clinical data activities (data management, programming, clinical data review, etc.). Guillaume holds a Master in Management of Clinical Operations and Data Management and is also a doctor in pharmacy.
Kahina is Pharmacometrician and PBPK Specialist. Her arrival will certainly strengthen our PBPK Modeling team. Before joining our company, Kahina worked in a large pharmaceutical group on many clinical projects (NDA submission, specific population, drug-drug interactions, etc.) and preclinical Discovery in FIH (prediction of the first male profile). Kahina is a doctor in pharmacy with a master's degree in PK Modeling.
Blaise is a Pharmacometrician and a PopPK Modeler. He is mainly responsible for pharmacokinetic and pharmacodynamic modeling and simulation activities with the population approach. Before joining our company, he worked in pharmacometrics in a large group, on different therapeutic areas, in pre-clinical and clinical settings. He holds a doctorate in pharmacy as well as a master's degree in PK Modeling.
Myra is a Pharmacometrician specialized in popPK. She will perform Population Pharmacokinetics and PK/PD modeling and simulations activities. Prior to joining our company, Myra worked on hepatic impairment classifications. She also developed an IVIVC model based on a compartmental approach. Myra holds a doctorate in pharmacy and a master’s degree in PK Modeling.
Arman is a Pharmacometrician specialized in Pharmacokinetics Non-Compartmental Analysis (NCA). He will perform NC analysis in CDISC compliant format. Prior to joining PhinC Development, he worked on a PopPK model development of a monoclonal antibody. Arman is a Doctor in Pharmacy and holds a Master’s degree in PK Modeling.
Thomas is a Biostatistician, in charge of statistical analysis related to clinical development and ECG data analysis. Before joining our company, he worked on several topics, Post-Market Clinical Follow-up Studies (PMCF), medical devices and Real World Data, but also on methodological support for customers in the choice of adapted study designs. Thomas holds a master's degree in Statistical Methodology in Biomedical Research.
Ibrahim is a PK scientist and is responsible of the execution of non-compartmental analyses. Prior to joining our company, Ibrahim worked on optimizing the usage of antibiotics in intensive care unit facilities through model-informed precision dosing by developing population pharmacokinetic models. Ibrahim has a background in drug development and is currently finishing his master’s degree in Pharmaceutical Sciences.
Sylvie is a Medical Writing Assistant and Administrative head. She has over 25 years of experience in assistantship and medical writing at CROs and pharmaceutical companies. Sylvie manages all the documentation of upstream clinical studies and study results and has in charge the administrative staff management. She is also responsible for the standardization of all documents, following ICHE3 standards and ECTD format.
Our team continues to grow with the arrival of a new Office Manager, Régina Ondélé. Régina has more than 10 years of experience in Office Management in international structures. At PhinC, she will ensure the proper functioning of the various services, and will be responsible for their coordination by managing the administrative part related to general resources, the organization of team work, mail and orders. Régina will also be in charge of monitoring the contracts and schedules of our R&D studies.
Thomas is Legal Manager and is an expert in contract law and pharmaceutical law. For almost 15 years, he has been using his dual expertise with pharmaceutical companies, biotechnology companies, CROs and bioanalytical service providers for drafting and contract negotiation, as well as participating in due diligence. Thomas has a Master's degree in Business Law completed with two Post Graduate Diploma in Health/Pharmaceutical Law and in applied Biology.
Olivia is a Legal Expert, her arrival will certainly strengthen the Legal Affairs team. Prior to joining our company, she practiced in a law firm for five years, both in advice and in litigation, in the health sector. Olivia dedicates her activity to the pharmaceutical industries, health establishments, biotechnologies and health professionals within the framework of their contractual practice and their legal, regulatory and ethical constraints.
Isabelle is Quality Manager and is in charge of setting up and monitoring the QMS. She has accumulated 10 years of practice in laboratories for the food industry, then 8 years in quality assurance within a CRO and two academic departments. Isabelle gained a specialization in the implementation of the ISO 9001 QMS and was able to understand the regulatory concepts applicable to the biotechnology sector, especially GLP. Isabelle holds a University Diploma in Technology specializing in Biological Engineering.
Angélique is in charge of administrative and accounting management. She manages treasury, customer invoicing, daily accounting entry and the development of dashboards and reporting. Angélique also manages the administrative staff and payroll and liaises with the accounting firm. Her degree in Business Administration and her experience of more than 10 years in small structures gives her a global vision of the company in terms of financial management.
Mohamed is Head of Communication and Marketing and has over 5 years of experience in the field of communication, events and marketing.
Mohamed manages the implementation of digital marketing projects and campaigns, such as SEO and SEA strategies and web-marketing.
He also creates and sets up various means and tools of communication. Mohamed holds a Master's degree in International Media and Communication.